
    
      EBV DNA has strongly association in NPC patient' disease status. It can provide informations
      of disease relapse or risks classification. In this study, we will investigate the impact of
      plasma EBV DNA concentration change during chemoradiotherapy on initial tumor response and
      long-term survival in patients with advanced nasopharyngeal carcinoma
    
  